CD4 and meningioma: Further, the detection of the infiltrated immune cells in meningioma tissues showed that there was a decreased expression of CD3+, CD4+ and CD8+ T lymphocytes in malignant meningioma, which implied PD-L1 blockade may not have outstanding effect for malignant meningioma therapy.